Zofran Birth Defect Lawsuits Cleared to Proceed Toward Trial in MDL
Zofran lawsuits are continuing forward after a federal judge rejected calls by GlaxoSmithKline for a summary judgment in the manufacturer’s favor.…
«
»
Zofran lawsuits are continuing forward after a federal judge rejected calls by GlaxoSmithKline for a summary judgment in the manufacturer’s favor.…
A new CDC report indicates a number of serious events have been linked to the use of Shingrix, but indicates the vaccine is safe overall.…
A new study shows a link between Zofran use during pregnancy and an increased risk of oral cleft defects.…
Doctors rapidly moving away from the Zostavax vaccine may be in part to blame for a shortage of Shingrix, GlaxoSmithKline’s competing vaccination, which has been overwhelmed by demand in recent months.…
A new study indicates Shingrix is more effective than Zostavax at preventing shingles, but may carry an increased risk of injection site complications.…
A motion to dismiss all Zofran lawsuits claims that the FDA never allowed the manufacturer to put birth defect warning labels on the medication.…
Endo International has finalized a Testim testosterone gel settlement agreement which will resolve about 1,300 lawsuits over heart attack and stroke injury claims.…
Three Zofran birth defect lawsuits were dismissed by a federal judge who says GlaxoSmithKline cannot be held liable in cases where women used a generic version of the drug.…
The CDC warns that some pharmacists may be confused over the differences between Zostavax and the new shingles vaccine, Shingrix, leading to vaccine administration errors.…
Parties involved in Zofran litigation will select 16 potential bellwether cases by June 15 for claims dealing with heart and face birth defects.…